Data / Form D filings / InGeneron, Inc.
InGeneron, Inc.: Form D filings
InGeneron, Inc., a biotechnology company in Houston, TX, filed 5 Form D notices with the SEC between 2016 and 2024. The latest, on March 4, 2024, reports $1.7 million sold of a $1.7 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8205 EL RIO, Houston, TX, 77054
- Phone
- (713) 440-9900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1678766
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | New notice | $1,749,181 | $1,749,181 | 10 | Feb 16, 2024 | sec.gov | |
| Apr 18, 2019 | New notice | $23,000,000 | $3,500,000 | $19,500,000 | 1 | Apr 5, 2019 | sec.gov |
| Mar 6, 2017 | New notice | $19,867,575 | $9,867,575 | $10,000,000 | 4 | Feb 17, 2017 | sec.gov |
| Dec 20, 2016 | New notice | $2,150,000 | $2,150,000 | 4 | Aug 4, 2016 | sec.gov | |
| Jul 7, 2016 | New notice | $4,500,005 | $4,500,005 | 5 | Oct 9, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amber Langner | Director | |
| Jerry Griffin | Director | |
| Klaus Keller | Director | |
| Bobby Griffin | Director | |
| Eckhard Alt | Executive Officer, Director | |
| Fabian Alt | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Mar 4, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what InGeneron, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.